NASDAQ · Biotechnology

KNSA (KNSA) Stock

$73.43 -1.23% NASDAQ: KNSA Healthcare

Valuation

MetricValue
Price$73.43
Market Cap$5.60B
P/E Ratio71.12
P/B Ratio7.06
P/S Ratio5.32
EPS (TTM)$0.75
52-Week High$79.33
52-Week Low$26.27
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE10.39%
ROA7.72%
ROCE13.56%
Gross Margin11.50%
Operating Margin11.36%
Net Margin9.69%
Debt/Equity0.01
Current Ratio3.79

Annual Financials (USD)

Metric20212022202320242025
Revenue$39.0M$220.0M$270.0M$423.0M$678.0M
Operating Profit$-157.0M$10.0M$-25.0M$-46.0M$77.0M
Net Profit$-158.0M$183.0M$14.0M$-43.0M$59.0M
EPS$-2.30$2.60$0.20$-0.60$0.75
Op Margin-406.4%4.4%-9.3%-10.8%11.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$233.0M$460.0M$526.0M$581.0M$764.0M
Total Liabilities$48.0M$64.0M$87.0M$142.0M$196.0M
Cash$122.0M$123.0M$108.0M$184.0M$166.0M
Borrowings$6.0M$6.0M$12.0M$10.0M$9.0M

Latest News

Kiniksa Pharmaceuticals International (KNSA) Joins Russell Indexes, Is The Upside Already Priced In? Simply Wall St. · Jul 9, 2026 Axsome Begins Phase III Study on Solriamfetol for ADHD in Children Zacks · Jul 8, 2026 AGIO's Filing for Mitapivat in SCD Gets FDA's Priority Tag, Stock Up Zacks · Jul 8, 2026 Illumina, Inc. (ILMN) Hit a 52 Week High, Can the Run Continue? Zacks · Jul 8, 2026 Kiniksa Pharmaceuticals International, plc (KNSA) Is a Great Choice for 'Trend' Investors, Here's Why Zacks · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-126.0M$6.0M$13.0M$26.0M$26.0M
Investing Cash Flow$108.0M$-8.0M$-30.0M$37.0M$37.0M
Financing Cash Flow$6.0M$-1.0M$1.0M$12.0M$12.0M
Net Cash Flow$8.0M$0$-15.0M$76.0M$76.0M
Free Cash Flow$-147.0M$6.0M$13.0M$25.0M$25.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA48.77
FCF Yield4.10%
Quick Ratio3.33
Interest Coverage—
Return 1Y123.61%
Return 3Y307.63%
Return 5Y349.12%

Ownership

Insiders Held3.58%
Institutions Held102.50%
Institutions Float Held106.31%
Institutional HolderSharesReport Date
FMR, LLC6,823,7002026-03-31
Rubric Capital Management LP3,750,0002026-03-31
Baker Bros. Advisors, LP2,826,2462026-03-31
Tang Capital Management, LLC2,259,8892026-03-31
Vanguard Portfolio Management LLC1,766,2682026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADPT $24.93 +5.64% -69.84 $3.99B 0.00%
APLSApellis Pharmaceuticals, Inc. $41.03 +0.00% 38.37 $5.25B 0.00%
CDTXCidara Therapeutics, Inc. $221.38 +0.00% -25.99 $5.61B 0.00%
CPRX $31.49 +0.00% 18.00 $3.85B 0.00%
FOLDAmicus Therapeutics Inc $14.49 +0.00% -161.00 $4.55B 0.00%

About KNSA

KNSA stock trades at $73.43 with a market capitalization of $5.60B. The stock is valued at a price-to-earnings (P/E) ratio of 71.12, price-to-book of 7.06, price-to-sales of 5.32. Over the past 52 weeks the stock has ranged between $26.27 and $79.33, and currently trades 7.4% below its 52-week high.

On profitability, KNSA generates a return on equity (ROE) of 10.39%, return on capital employed of 13.56%, an operating margin of 11.36%, a net profit margin of 9.69%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides